Ziv-aflibercept: A cost-effective, off-label, highly potent antagonist of vascular endothelial growth factor

Mansour, AM; Stewart, MW; Farah, ME; Mansour, HA; Chhablani, J

Mansour, AM (reprint author), Amer Univ Beirut, Dept Ophthalmol, Beirut, Lebanon.

ACTA OPHTHALMOLOGICA, 0; ():

Abstract

Ziv-aflibercept (Zaltrap), a recombinant fusion protein that binds diffusible vascular endothelial growth factor (VEGF), is approved for the treatment......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索